392 related articles for article (PubMed ID: 19700654)
1. Incremental advances in excremental cancer detection tests.
Itzkowitz SH
J Natl Cancer Inst; 2009 Sep; 101(18):1225-7. PubMed ID: 19700654
[No Abstract] [Full Text] [Related]
2. Fecal DNA biomarkers for the detection of colorectal neoplasia: attractive, but is it feasible?
Brenner DE; Rennert G
J Natl Cancer Inst; 2005 Aug; 97(15):1107-9. PubMed ID: 16077063
[No Abstract] [Full Text] [Related]
3. [Fecal methylated DNA for the detection of colorectal cancer].
von Delius S; Jung A; Schmid RM
Z Gastroenterol; 2006 Sep; 44(9):1001-2. PubMed ID: 16981074
[No Abstract] [Full Text] [Related]
4. Identification of colorectal adenomas by a quantitative immunochemical faecal occult blood screening test depends on adenoma characteristics, development threshold used and number of tests performed.
Rozen P; Levi Z; Hazazi R; Waked A; Vilkin A; Maoz E; Birkenfeld S; Leshno M; Niv Y
Aliment Pharmacol Ther; 2009 Apr; 29(8):906-17. PubMed ID: 19183147
[TBL] [Abstract][Full Text] [Related]
5. Sex differences in performance of fecal occult blood testing.
Brenner H; Haug U; Hundt S
Am J Gastroenterol; 2010 Nov; 105(11):2457-64. PubMed ID: 20700114
[TBL] [Abstract][Full Text] [Related]
6. N-Myc downstream-regulated gene 4 (NDRG4): a candidate tumor suppressor gene and potential biomarker for colorectal cancer.
Melotte V; Lentjes MH; van den Bosch SM; Hellebrekers DM; de Hoon JP; Wouters KA; Daenen KL; Partouns-Hendriks IE; Stessels F; Louwagie J; Smits KM; Weijenberg MP; Sanduleanu S; Khalid-de Bakker CA; Oort FA; Meijer GA; Jonkers DM; Herman JG; de Bruïne AP; van Engeland M
J Natl Cancer Inst; 2009 Jul; 101(13):916-27. PubMed ID: 19535783
[TBL] [Abstract][Full Text] [Related]
7. Analysis of DNA methylation in bowel lavage fluid for detection of colorectal cancer.
Harada T; Yamamoto E; Yamano HO; Nojima M; Maruyama R; Kumegawa K; Ashida M; Yoshikawa K; Kimura T; Harada E; Takagi R; Tanaka Y; Aoki H; Nishizono M; Nakaoka M; Tsuyada A; Niinuma T; Kai M; Shimoda K; Shinomura Y; Sugai T; Imai K; Suzuki H
Cancer Prev Res (Phila); 2014 Oct; 7(10):1002-10. PubMed ID: 25139296
[TBL] [Abstract][Full Text] [Related]
8. [New tests for the prevention of colorectal cancer].
Herzog J; Eickhoff A; Riemann JF
Dtsch Med Wochenschr; 2012 Sep; 137(37):1814-7. PubMed ID: 22956226
[No Abstract] [Full Text] [Related]
9. Detection of hypermethylated DNA or cyclooxygenase-2 messenger RNA in fecal samples of patients with colorectal cancer or polyps.
Leung WK; To KF; Man EP; Chan MW; Hui AJ; Ng SS; Lau JY; Sung JJ
Am J Gastroenterol; 2007 May; 102(5):1070-6. PubMed ID: 17378912
[TBL] [Abstract][Full Text] [Related]
10. Re: Protection from right- and left-sided colorectal neoplasms after colonoscopy: population-based study.
Worthley DL; Hewett DG; Spring KJ; Whitehall VL; Leggett BA
J Natl Cancer Inst; 2010 Jul; 102(13):990; author reply 990-1. PubMed ID: 20516399
[No Abstract] [Full Text] [Related]
11. Detection in fecal DNA of colon cancer-specific methylation of the nonexpressed vimentin gene.
Chen WD; Han ZJ; Skoletsky J; Olson J; Sah J; Myeroff L; Platzer P; Lu S; Dawson D; Willis J; Pretlow TP; Lutterbaugh J; Kasturi L; Willson JK; Rao JS; Shuber A; Markowitz SD
J Natl Cancer Inst; 2005 Aug; 97(15):1124-32. PubMed ID: 16077070
[TBL] [Abstract][Full Text] [Related]
12. [Comparison of different stool tests for the detection of cancer of the colon].
Vogel T; Driemel C; Hauser A; Hansmann A; Lange S; Jonas M; Möslein G
Dtsch Med Wochenschr; 2005 Apr; 130(14):872-7. PubMed ID: 15800820
[TBL] [Abstract][Full Text] [Related]
13. Virtual colonoscopy. A new option in colon cancer screening.
Mayo Clin Womens Healthsource; 2009 Apr; 13(4):1-2. PubMed ID: 19255534
[No Abstract] [Full Text] [Related]
14. Novel molecular screening approaches in colorectal cancer.
Miller S; Steele S
J Surg Oncol; 2012 Apr; 105(5):459-67. PubMed ID: 22441897
[TBL] [Abstract][Full Text] [Related]
15. [Screening for colorectal cancer in high-risk and intermediate-risk subject: what's the best tool?].
Trevisani L; Cifalà V; Sartori S; Tombesi P; Matarese V; Pezzoli A; Abbasciano V
Recenti Prog Med; 2009 Feb; 100(2):68-72. PubMed ID: 19350797
[TBL] [Abstract][Full Text] [Related]
16. A smarter strategy? Reflections on fecal DNA screening for colorectal cancer.
Woolf SH
N Engl J Med; 2004 Dec; 351(26):2755-8. PubMed ID: 15616212
[No Abstract] [Full Text] [Related]
17. Fecal DNA for colorectal-cancer screening.
Frossard JL; de Peyer R
N Engl J Med; 2005 Mar; 352(13):1384-5; author reply 1384-5. PubMed ID: 15800239
[No Abstract] [Full Text] [Related]
18. Clinical practice guidelines: quality of colonoscopy in colorectal cancer screening.
Jover R; Herráiz M; Alarcón O; Brullet E; Bujanda L; Bustamante M; Campo R; Carreño R; Castells A; Cubiella J; García-Iglesias P; Hervás AJ; Menchén P; Ono A; Panadés A; Parra-Blanco A; Pellisé M; Ponce M; Quintero E; Reñé JM; Sánchez del Río A; Seoane A; Serradesanferm A; Soriano Izquierdo A; Vázquez Sequeiros E; ;
Endoscopy; 2012 Apr; 44(4):444-51. PubMed ID: 22438159
[No Abstract] [Full Text] [Related]
19. Multitarget stool DNA test: clinical performance and impact on yield and quality of colonoscopy for colorectal cancer screening.
Johnson DH; Kisiel JB; Burger KN; Mahoney DW; Devens ME; Ahlquist DA; Sweetser S
Gastrointest Endosc; 2017 Mar; 85(3):657-665.e1. PubMed ID: 27884518
[TBL] [Abstract][Full Text] [Related]
20. Capsule endoscopy versus colonoscopy.
Hsu CS; Kao JH
N Engl J Med; 2009 Oct; 361(16):1608; author reply 1609-10. PubMed ID: 19842249
[No Abstract] [Full Text] [Related]
[Next] [New Search]
